Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: A patient-level propensity-matched analysis

European Heart Journal

Volumn 40, Issue 17, 2019, Pages 1334-1339

  Seeger, Julia ^a   Kapadia, Samir R ^b   Kodali, Susheel ^c   Linke, Axel ^d   Wöhrle, Jochen ^a   Haussig, Stephan ^d   Makkar, Raj ^e   Mehran, Roxana ^f   Rottbauer, Wolfgang ^a   Leon, Martin ^c  

^a UNIVERSITY OF ULM   (Germany)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Department of Medicine   (United States)

^d University Heart Center Dresden   (Germany)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral embolic protection; Outcome; Stroke; TAVR

Indexed keywords

AGED; ALL CAUSE MORTALITY; ARTICLE; CEREBROVASCULAR ACCIDENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ODDS RATIO; PRIORITY JOURNAL; PROPENSITY SCORE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VERY ELDERLY; ADVERSE EVENT; AORTIC VALVE STENOSIS; BRAIN EMBOLISM; CASE CONTROL STUDY; COMPLICATION; CONTROLLED CLINICAL TRIAL (TOPIC); EMBOLIC PROTECTION DEVICE; MORTALITY; PERIOPERATIVE PERIOD; SEVERITY OF ILLNESS INDEX;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CASE-CONTROL STUDIES; EMBOLIC PROTECTION DEVICES; FEMALE; HUMANS; INTRACRANIAL EMBOLISM; MALE; NON-RANDOMIZED CONTROLLED TRIALS AS TOPIC; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK REDUCTION BEHAVIOR; SEVERITY OF ILLNESS INDEX; STROKE; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 85063273851     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehy847     Document Type: Article

References (31)

1. Bernick C, Kuller L, Dulberg C, Longstreth WT Jr, Manolio T, Beauchamp N, Price T; Cardiovascular Health Study Collaborative Research Group. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 2001;57:1222-1229.
2. Fairbairn TA, Mather AN, Bijsterveld P, Worthy G, Currie S, Goddard AJ, Blackman DJ, Plein S, Greenwood JP. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 2012;98:18-23.
3. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007;6:611-619.
4. Eggebrecht H, Schmermund A, Voigtländer T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10, 037 published patients. EuroIntervention 2012;8:129-138.
5. Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, Neumann FJ, Tarantini G, Zamarano JL, Vahanian A. SOURCE 3 registry: design and 30-day results of the European postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve. Circulation 2017;135: 1123-1132.
6. Haussig S, Mangner N, Dwyer MG, Lehmkuhl L, Lücke C, Woitek F, Holzhey DM, Mohr FW, Gutberlet M, Zivadinov R, Schuler G, Linke A. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA 2016;316:592-601.
7. Kapadia SR, Kodali S, Makkar R, Mehran R, Lazar RM, Zivadinov R, Dwyer MG, Jilaihawi H, Virmani R, Anwaruddin S, Thourani VH, Nazif T, Mangner N, Woitek F, Krishnaswamy A, Mick S, Chakravarty T, Nakamura M, McCabe JM, Satler L, Zajarias A, Szeto WY, Svensson L, Alu MC, White RM, Kraemer C, Parhizgar A, Leon MB, Linke A; SENTINEL Trial Investigators. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol 2017;69: 367-377.
8. Rogers T, Alraies C, Torguson R, Waksman R. Overview of the 2017 US Food and Drug Administration circulatory system devices panel meeting on the Sentinel cerebral protection system. Am Heart J 2017;192:113-119.
9. Kapadia SR. Routine use of embolic protection during transcatheter aortic valve replacement. JACC Cardiovasc Interv 2017;10:2304-2306.
10. Van Mieghem NM, van Gils L, Ahmad H, van Kesteren F, van der Werf HW, Brueren G, Storm M, Lenzen M, Daemen J, van den Heuvel AF, Tonino P, Baan J, Koudstaal PJ, Schipper ME, van der Lugt A, de Jaegere PP. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention 2016;12:499-507.
11. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:1438-1454.
12. Pagnesi M, Martino EA, Chiarito M, Mangieri A, Jabbour RJ, Van Mieghem NM, Kodali SK, Godino C, Landoni G, Colombo A, Latib A. Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: a systematic review and meta-analysis. Int J Cardiol 2016;221: 97-106.
13. Latib A, Pagnesi M. Cerebral embolic protection during transcatheter aortic valve replacement. A disconnect between logic and data? J Am Coll Cardiol 2017;69: 378-380.
14. Giustino G, Sorrentino S, Mehran R, Faggioni M, Dangas G. Cerebral embolic protection during TAVR: a clinical event meta-analysis. J Am Coll Cardiol 2017;69: 465-466.
15. Lansky AJ, Brown D, Pena C, Pietras CG, Parise H, Ng VG, Meller S, Abrams KJ, Cleman M, Margolis P, Petrossian G, Brickman AM, Voros S, Moses J, Forrest JK. Neurologic complications of unprotected transcatheter aortic valve implantation (from the neuro-TAVI trial). Am J Cardiol 2016;118:1519-1526.
16. Goldberg I, Auriel E, Russell D, Korczyn AD. Microembolism, silent brain infarcts and dementia. J Neurol Sci 2012;322:250-253.
17. van Rooij FG, Schaapsmeerders P, Maaijwee NA, van Duijnhoven DA, de Leeuw FE, Kessels RP, van Dijk EJ. Persistent cognitive impairment after transient ischemic attack. Stroke 2014;45:2270-2274.
18. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222.
19. Ghanem A, Kocurek J, Sinning JM, Wagner M, Becker BV, Vogel M, Schröder T, Wolfsgruber S, Vasa-Nicotera M, Hammerstingl C, Schwab JO, Thomas D, Werner N, Grube E, Nickenig G, Müller A. Cognitive trajectory after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2013;6:615-624.
20. Fanning JP, Wesley AJ, Wong AA, Fraser JF. Emerging spectra of silent brain infraction. Stroke 2014;45:3461-3471.
21. Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-Hayes M, Romero JR, Kase CS, Wolf PA, Seshadri S. Association of MRI markers of vascular brain injury with incident stroke mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010;41:600-606.
22. Seeger J, Gonska B, Otto M, Rottbauer W, Wöhrle J. Cerebral embolic protection during transfemoral aortic valve replacement significantly reduces death and stroke compared with unprotected procedures. JACC Cardiovasc Interv 2017;10: 2297-2303.
23. Kleiman NS, Maini BJ, Reardon MJ, Conte J, Katz S, Rajagopal V, Kauten J, Hartman A, McKay R, Hagberg R, Huang J, Popma J; CoreValve Investigators. Neurological events following transcatheter aortic valve replacement and their predictors: a report from the CoreValve trials. Circ Cardiovasc Interv 2016;9: pii: e003551. doi: 10.1161/CIRCINTERVENTIONS.115.003551.
24. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG; PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609-1620.
25. Arnold M, Schulz-Heise S, Achenbach S, Ott S, Dorfler A, Ropers D, Feyrer R, Einhaus F, Loders S, Mahmoud F, Roerick O, Daniel WG, Weyand M, Ensminger SM, Ludwig J. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc Interv 2010;3: 1126-1132.
26. Rodés-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bédard F, Doyle D, De Larochellière R, Jayasuria C, Villeneuve J, Marrero A, Côté M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol 2011;57:18-28.
27. Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, Johansson U, Wendt D, Jakob HG, Forsting M, Sack S, Erbel R, Eggebrecht H. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010;121:870-878.
28. Ghanem A, Müller A, Nähle CP, Kocurek J, Werner N, Hammerstingl C, Schild HH, Schwab JO, Mellert F, Fimmers R, Nickenig G, Thomas D. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 2010;55:1427-1432.
29. Uddin A, Fairbairn T, Djoukhader I, Currie S, Steadman CD, Motwani M, Kidambi A, Goddard A, Blackman S, McCann GP, Plein S, Greenwood JP. Difference between cerebral embolic events following transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR): a diffusion weighted MRI study. J Cardiovasc Magn Reson 2013;15:O59.
30. Astarci P, Price J, Glineur D, D'Hoore W, Kefer J, Elkhoury G, Grandin C, Vanoverschelde JL. Cerebral embolization during percutaneous valve implantation does not occur during balloon inflation valvuloplasty: prospective diffusionweighted brain MRI study. J Heart Valve Dis 2013;22:79-84.
31. Van Gils L, Kroon H, Daemen J, Ren C, Maugenest AM, Schipper M, De Jaegere PP, Van Mieghem NM. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement. Catheter Cardiovasc Interv 2018;91:790-797.